Jump to content
Business Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
ULYSSES99 SEARCH ENGINE             CONTACT US

rootsanalysismarket01

Members
  • Content Count

    7
  • Joined

  • Last visited

Community Reputation

0 Neutral
  1. Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: · A detailed assessment of the current market landscape of drug developers engag
  2. Roots Analysis has done a detailed study on Medical Device CROs for Regulatory Affairs Management Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights · Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities · The market landscape is highly fragmented, featuring the presence of both established players and new entrants; majority of such firms are located in the developed geo
  3. Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights · Several players are currently engaged in the development and / or manufacturing of different types of cobots for a wide variety of operations, including both simple and precision tasks · Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being actively adopted across various industrie
  4. Roots Analysis has done a detailed study on China Pharmaceutical Contract Manufacturing Services Market, 2020-2030, covering key aspects of the industry and identifying key future growth opportunities. Key Market Insights · Presently, over 100 CMOs across the globe claim to have manufacturing facilities in China, offering services for pharmaceutical API, intermediates and FDF manufacturing · CMOs have established manufacturing facilities across different regions of China; Eastern China has emerged as a popular hub, serving as a base of operations for many contract
  5. Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well. The USD 3.7 billion (by 2030) financial opportunity within the encapsulated Cell Therapies and Encapsulation Technologies Market has been analyzed across the following segments: Type of licensin
  6. Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030, covering key aspects of the industry and identifying key future growth opportunities. Key Market Insights · Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain · Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; major
  7. Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights · More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are 35+ technology platforms for the development of BBB penetrant drugs · Majority of drug candidates are currently in the early s
×
×
  • Create New...